Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 28, 2005; 11(36): 5621-5626
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5621
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5621
Table 1 MDR1, LRP primers
| Gene | Quantification method | Sequence (5’–3’) | Size (bp) |
| MDR1 | Forward primer | CATTGGTGTGGTGAGTCAGG | 176 |
| Reverse primer | CTCTCTCTCCAACCAGGGTG | ||
| LRP | Forward primer | TAAGGGCTTCCAGCACCAAC | 237 |
| Reverse primer | GGAGTTCTCGCTTCTCGTCC | ||
| TNF-α | Forward primer | GCGGATTCATGAGCACTGAAAGCATGATCC | 725 |
| Reverse primer | CCCAAGCTTTCACAGGGCAATGATCCCAAAG | ||
| β -actin | Forward primer | GTGCGTGACATTAAGGAG | 530 |
| Reverse primer | CTAAGTCATAGTCCGCCT |
- Citation: Ding L, Chen XP, Zhang ZW, Guan J, Zhang WG, Wang HP, Wang ZH, Li CL. Synergistic effect of bromocriptine and tumor necrosis factor-α on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of liver neoplasm. World J Gastroenterol 2005; 11(36): 5621-5626
- URL: https://www.wjgnet.com/1007-9327/full/v11/i36/5621.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i36.5621